Masitinib Prostate Cancer Trial Gains FDA and E...

By HEOR Staff Writer

July 8, 2025

What is the latest on the masitinib prostate cancer trial, and how could it change treatment for metastatic castrate-resistant prostate cancer (mCRPC)? The masitinib prostate cancer trial recently received simultaneous authorizations from both ...